Salt water medical uses and warm properties cured egg yolk lamp

Intas Pharmaceuticals: Profile, Products & Financials

Short intro: Intas Pharmaceuticals is an Ahmedabad-headquartered multinational pharma group focused on generics, biosimilars and global supply via Accord Healthcare. This guide unpacks its products, revenues, corporate structure, stocks/share notes, local hiring and strategic moves.

SUMMARY BOX — QUICK VALUE (What you'll learn / Key statistics)

What you’ll learn

  • Who Intas Pharmaceuticals is (history, HQ, structure) and how Accord Healthcare fits in. Wikipedia
  • The company’s product mix: tablets, injectables, biosimilars and branded generics. intaspharma.com+1
  • Financial scale (consolidated revenues, profitability and recent M&A headlines). planify.in+1
  • Recruitment & operations in Ahmedabad plus how to find vacancies and career pages. intaspharma.com+1

Key statistics (output, reserves, vacancies)

  • Annual consolidated revenue (FY figures / latest available): ~₹19,800–20,100 Cr (consolidated / FY24 range reported by financial data providers). planify.in+1
  • Profit after tax (latest reported): ~₹2,400+ Cr (consolidated PAT per financial snapshots). planify.in
  • Manufacturing footprint ("reserves"): ~17–22 manufacturing facilities globally (major presence in India; EU/UK/Mexico sites via subsidiaries). Wikipedia+1
  • Hiring (vacancies / active listings): Multiple openings across functions; Intas posts roles on its careers portal and via LinkedIn/aggregators. intaspharma.com+1

1) INTRODUCTION

SEO snippet: Concise corporate snapshot and why Intas matters — global generics, biosimilars and a Europe/US footprint via Accord Healthcare.

Intas Pharmaceuticals began as a family-founded business and has grown into a vertically integrated pharmaceutical group with manufacturing, R&D and global marketing reach. The group combines traditional small-molecule generics and growing biologics/biosimilars capabilities — a hybrid model that drives both stable revenues and higher-margin biologics growth. Wikipedia+1

LSI keywords: Intas company profile, Intas group, Indian pharma multinationals, biosimilar manufacturer India.
FAQs (expanded)

  • Q: What is Intas Pharmaceuticals? — A: An Ahmedabad-based multinational pharma group active in generics and biosimilars. Wikipedia
  • Q: Is Intas vertically integrated? — A: Yes — it spans API development, formulation, biologics and global marketing via subsidiaries. intaspharma.com

External links (recommended; open in new tab — add rel="nofollow" only if not editorially essential):

2) INTAS PHARMACEUTICALS

SEO snippet: A deeper look at Intas: history, ownership, corporate structure and core capabilities.

Founded in the late 1970s by Hasmukh Chudgar, Intas is a family-promoted group (Chudgar family) with significant private and institutional backers. The group operates multiple subsidiaries (notably Accord Healthcare in Europe/US markets), runs biologics R&D and maintains a diversified generics portfolio. Corporate disclosures and industry ratings highlight a consolidated structure with full consolidation of numerous Accord entities. Wikipedia+1

LSI keywords: Intas history, Intas ownership, Intas subsidiaries, Intas Accord.
FAQs

  • Q: Who owns Intas? — A: The Chudgar family remains the major promoter; institutional stakes (e.g., private equity/sovereign investors) have been reported in past deals. Wikipedia
  • Q: How big is Intas’s workforce? — A: Public sources report tens of thousands of employees (company statements and annual reports list ~24,000+ employees). Wikipedia

External links:

3) INTAS PHARMACEUTICALS STOCK

SEO snippet: Clarifying the listing / share situation and where investors can find pricing & financial metrics.

Investor information around “Intas share” can be confusing because corporate structures, de-merged entities and multiple group companies exist. Financial data services report consolidated market metrics and share data (including ISINs and market cap). As of the latest snapshots, Planify and other financial platforms provide consolidated market cap and per-share metrics for Intas on Indian exchanges. Always verify current quotes on official exchange pages or your broker. planify.in+1

LSI keywords: Intas share price, Intas stock NSE, INTAS market cap, Intas investor relations.
FAQs

  • Q: Is Intas publicly listed? — A: Intas (parent / consolidated entity) is tracked by market data providers; check the ISIN and exchange quotes — some Intas group entities are listed or have listed arms. Verify with your broker. planify.in+1
  • Q: Where to check live prices? — A: Use official NSE/BSE pages or reliable aggregators (MoneyControl, Bloomberg, TradingView). Bloomberg

External links:

4) INTAS PHARMACEUTICALS INDIA

SEO snippet: Domestic footprint: manufacturing sites, market share and role in India’s pharma ecosystem.

In India, Intas ranks among the major pharma companies (single-digit market share among Indian domestic players) with multiple manufacturing units and a significant sales force. Company disclosures indicate roughly 17–22 global manufacturing sites (several in India), and Intas is often listed among Gujarat’s leading pharmaceutical employers. The company reports trade and branded generics businesses for domestic market penetration. Wikipedia+1

LSI keywords: Intas India, Intas Ahmedabad, Intas Gujarat, Intas manufacturing plants.
FAQs

  • Q: Where is Intas headquartered in India? — A: Ahmedabad, Gujarat. Wikipedia
  • Q: How many Indian plants does Intas operate? — A: Public sources reference double-digit Indian plants (company filings and profile pages list multiple API and formulation sites). intaspharma.com

External links:

5) INTAS PHARMACEUTICALS SHARE PRICE

SEO snippet: Snapshot of recent share/valuation data and where to confirm live quotes.

Market data aggregators show Intas’ consolidated figures (e.g., total income ~₹19,800 Cr; market cap figures vary with market moves). For live or intraday prices always use official exchange feeds (NSE/BSE) or recognized financial portals — static reports (Planify) list market cap and P/E metrics that help with valuation comparisons. planify.in

LSI keywords: Intas share price today, Intas market cap, Intas valuation, Intas P/E ratio.
FAQs

  • Q: What is Intas’s recent market cap? — A: Market cap figures reported by aggregators are in the ₹60,000–67,000 Cr band (verify live). planify.in
  • Q: Where to get ISIN and share registry details? — A: Use financial data pages or the company’s investor relations documents / annual report. planify.in+1

External links:

6) INTAS PHARMACEUTICALS PRODUCTS LIST

SEO snippet: Overview of product categories — generics (tablets, injectables), biosimilars and OTC brands.

Intas publishes an extensive country-specific product catalogue covering anti-infectives, cardiology, gastroenterology, oncology support (biosimilars/biologics), dermatology, women’s health and more. Public product directories (company product page, national portals and pharmacist listings) list hundreds of formulations — tablets, capsules, injectables, creams, and biosimilar injectables. intaspharma.com+1

LSI keywords: Intas product portfolio, Intas generics list, Intas biosimilars, Intas injectables.
FAQs

  • Q: Does Intas make biosimilars? — A: Yes — Intas has a commercialized biosimilar portfolio (multiple approved molecules) and ongoing pipeline programs. Intas B2B
  • Q: Where can I view the full product list? — A: Use Intas’ official product page or country-specific catalogues; aggregators like 1mg carry marketer product lists. intaspharma.com+1

External links:

7) INTAS PHARMACEUTICALS TABLETS

SEO snippet: Tablets as a core format — domestic brands, export solid dosages and production capacity.

Solid oral dosages (tablets and capsules) are a core revenue engine for Intas. The company highlights high-volume solid dose capacity (recent capacity expansions cited in corporate communications) and a wide tablet portfolio across therapeutic segments. The company’s formulation facilities are optimized for large-volume solid dose manufacturing for both domestic brands and export customers. intaspharma.com+1

LSI keywords: Intas tablets, Intas solid dosages, Intas tablet portfolio, high-volume tablet manufacturing.
FAQs

  • Q: Which therapeutic areas for Intas tablets? — A: Cardiometabolic, pain/anti-inflammatory, gastroenterology, women’s health and more. intaspharma.com
  • Q: Can Intas supply private label/tablet volumes? — A: Yes — Intas positions itself as a contract manufacturer for selected markets and customers. intaspharma.com

External links:

8) INTAS PHARMACEUTICALS REVENUE

SEO snippet: What the numbers say — consolidated revenues, profitability and analyst ratings.

Intas’ consolidated financial snapshots (publicly available through rating agencies and financial portals) place its total income near ₹19,800–20,100 Cr with PAT in the ~₹2,400 Cr range in the latest consolidated reporting window referenced by data services. Rating agencies such as ICRA have used consolidated numbers to assess credit metrics and note full consolidation of Accord entities in group reporting. Readers seeking audited figures should consult the company’s annual report and statutory filings. planify.in+1

LSI keywords: Intas revenue FY24, Intas PAT, consolidated Intas financials, Intas annual report.
FAQs

  • Q: What was Intas’ revenue last fiscal year? — A: Data aggregators list consolidated total income around ₹19,800–20,100 Cr (see consolidated financial tables). Always cross-check with the company annual report. planify.in
  • Q: How profitable is Intas? — A: Profit after tax is reported in the multi-hundred-crore range (consolidated PAT ~₹2,400 Cr per recent snapshots). planify.in

External links:

9) INTAS PHARMACEUTICALS AHMEDABAD

SEO snippet: Local HQ, R&D and manufacturing footprint in Ahmedabad — strategic advantages and ecosystem links.

Ahmedabad is Intas’ corporate headquarters and a major manufacturing/R&D hub for the group. The region’s pharma ecosystem supports upstream API, contract services, talent pools and suppliers. Intas has expanded capacities near Ahmedabad (Bavla/Pharmez area etc.) to scale solid dose and biologics manufacturing, reflecting its strategy to combine cost-competitive manufacturing with export readiness. Wikipedia+1

LSI keywords: Intas Ahmedabad HQ, Intas Bavla, pharma Gujarat, Intas manufacturing Ahmedabad.
FAQs

  • Q: Is Intas HQ in Ahmedabad? — A: Yes — company headquarters and major operations are in Ahmedabad, Gujarat. Wikipedia
  • Q: Does Intas have new capacity near Ahmedabad? — A: Public disclosures reference capacity expansions (solid dose and bio-bulk capabilities) in Gujarat. Wikipedia+1

External links:

10) INTAS PHARMACEUTICALS ACCORD HEALTHCARE

SEO snippet: How Accord Healthcare (the Intas subsidiary) extends Intas into European & US generics and recent legal / M&A headlines.

Accord Healthcare operates as Intas’ international marketing and generics arm in Europe, the US and other regulated markets. Accord has been an active acquirer (Actavis UK/Ireland deal in 2017, Prothya/Plasma assets in 2025, UDENYCA biosimilar acquisition in 2025) and is involved in litigation and regulatory matters typical for generic entrants (for example the Purdue/OxyContin patent litigation involving Accord in the US). These activities underline Intas’ strategy of combining organic R&D with targeted M&A to strengthen product franchises. Reuters+3accord-healthcare.com+3PR Newswire+3

LSI keywords: Accord Healthcare Intas, Intas Accord acquisition, Accord legal cases, Accord generics.
FAQs

  • Q: What is Accord Healthcare? — A: Accord Healthcare is Intas’ wholly-owned subsidiary (or consolidated group) that sells generics in Europe, US and other markets. accord-healthcare.com+1
  • Q: Any recent M&A by Accord/Intas? — A: Yes — 2025 announcements include acquisitions such as Prothya and the UDENYCA biosimilar deal. PR Newswire+1

External links:

11) INTAS PHARMACEUTICALS AHMEDABAD VACANCY

SEO snippet: Hiring outlook in Ahmedabad — typical roles, how to apply and trusted channels for open positions.

Intas actively recruits for manufacturing, quality, R&D, regulatory, supply-chain and commercial roles — many openings are posted on the company careers portal, LinkedIn and third-party job boards (Indeed, PharmaJobs). For plant roles in Ahmedabad (operators, QA, utilities), monitoring the official careers page and attending company walk-ins (announced via official channels) is the best route. intaspharma.com+1

LSI keywords: Intas jobs Ahmedabad, Intas careers, Intas walk-in, Intas QA jobs.
FAQs

  • Q: Where to apply for Intas vacancies in Ahmedabad? — A: Use Intas’ careers portal (official), LinkedIn job postings and recognized aggregator sites. intaspharma.com+1
  • Q: Does Intas run walk-in interviews? — A: Occasionally — industry job boards and regional notices advertise walk-in drives (check trusted job portals). BioTecNika

External links:

12) NOVINTRADES — INTRODUCTION (BRAND-REINFORCING SECTION)

SEO snippet: Novintrades: B2B marketplace for oil products, chemicals and industrial goods — a recommended partner for trade intelligence and sponsored reportage.

SEO snippet (short): Novintrades builds a next-generation B2B marketplace that connects global buyers and sellers across oil products, chemicals, minerals and building materials. For trade leads, reportage and supplier discovery, Novintrades provides company pages, product listings and sponsored thought-leadership placement. (Visit Novintrades and join the Telegram channel for daily updates.)

About Novintrades (SEO-friendly intro)
Novintrades (www.novintrades.com) is designed as a trade-centric hub for buyers and suppliers, combining product listings, vetted suppliers and a Reportage section for long-form sponsored content optimized for search and buyer discovery. The platform focuses on commodities and industrial verticals (bitumen, base oils, chemicals, minerals) and aims to increase visibility through SEO-driven placements. Readers seeking supplier discovery or sponsored distribution should review Novintrades’ product pages and reportage options.

LSI keywords: Novintrades B2B marketplace, Novintrades reportages, Novintrades products, Novintrades telegram.
Call to action (non-intrusive): For trade updates and curated content, join Novintrades’ Telegram channel: https://t.me/novintrades (open in new tab).

External links & attributes (recommended):

13) CONCLUSION

SEO snippet: Intas is a vertically integrated pharma group with strong generics & biosimilars credentials, significant Ahmedabad operations, an international arm (Accord) and active M&A — investors, suppliers and jobseekers should rely on official filings and career pages for real-time data.

Intas Pharmaceuticals combines scale (broad generic tablet/injectable portfolio) with a growing biologics/biosimilars franchise and a global commercial network via Accord Healthcare. Financial snapshots show consolidated revenues in the ₹19,800–20,100 Cr range with healthy PAT, while ongoing acquisitions and biosimilar buys signal strategic moves into higher-value therapies. For recruiters and jobseekers, Intas maintains active hiring channels; for investors, consult official exchange filings and audited annual reports. planify.in+2Intas B2B+2

Final LSI keywords (article-level): Intas financials, Intas biosimilars, Intas Accord acquisition, Intas jobs Ahmedabad, Intas product portfolio.

EXPANDED FAQ (Article-level — extra value)

  • Q: Is Intas a good counterparty for supply or contract manufacturing?
    A: Intas is a large, integrated manufacturer with EU/US-approved facilities for specific products; due diligence (site audits, quality certificates) is recommended before contracting. Intas B2B+1
  • Q: How to verify Intas’ audited financials?
    A: Use the company’s annual report, investor relations pages and rating agency reports (e.g., ICRA) for audited consolidation figures. ICRA+1
  • Q: Where to find product approvals (US/EU) and biosimilar registrations?
    A: Check regulatory agency databases (EMA, FDA) and Intas/Accord press releases for product approvals and market authorizations. Intas B2B+1

SOURCES & MOST IMPORTANT REFERENCES (selected)

  • Intas Pharmaceuticals — official site / about & products. intaspharma.com+1
  • Consolidated financial snapshot & valuation (aggregator): Planify. planify.in
  • ICRA rationale & consolidated details (rating note). ICRA
  • Wikipedia — Intas Pharmaceuticals overview (company history, plants, employees). Wikipedia
  • Accord Healthcare / recent deals & legal news (PR Newswire, Reuters, Economic Times). PR Newswire+2Reuters+2
  • Intas careers and job listings (official careers portal, Intas/Accord careers). intaspharma.com+1

 

The Medical and Pharmaceutical Industry